Pharma Mar, S.A.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PHMMF | 1875.HK | 688382.SS | AAPG | RCUS | 1873.HK | |
|---|---|---|---|---|---|---|
| Market cap | 1.22B | 2.56B | 8.38B | 1.41B | 2.43B | 2.80B |
| P/E (TTM) | 15.5 | — | — | — | — | 16.9 |
| Forward P/E | — | 42.9 | -43.8 | -23.3 | -6.2 | 6.2 |
| Price/book | 4.6 | 3.8 | 6.6 | 16.9 | 3.8 | 0.6 |
| Dividend yield | 1.62% | — | — | — | — | — |
| 1-year change | −23.98% | +69.54% | −48.70% | −53.43% | −1.28% | −43.17% |
| Today | 0.00% | +5.54% | +4.33% | +11.75% | +2.12% | +5.04% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All PHMMF news ›Pharma Mar (OTCMKTS:PHMMF) Sets New 1-Year Low – Here’s What Happened
Posted by Danessa Lincoln on Oct 31st, 2026 Shares of Pharma Mar (OTCMKTS:PHMMF – Get Free Report) reached a new 52-week low during trading on Thursday. The stock traded as low as $77.09 and last traded at $77.09, with a volume of 360…
Pharma Mar (PHMMF) Projected to Release Earnings on Thursday
Posted by Defense World Staff on Oct 28th, 2026 Pharma Mar (OTCMKTS:PHMMF – Get Free Report) will likely be posting its resultson Thursday, October 29th. Analysts expect Pharma Mar to post earnings of $0.0038 per share and revenue of…
Pharma Mar
S.A. is a Spain-based biopharmaceutical company focused on discovering, developing and commercializing medicines derived from marine organisms. The company’s primary area of activity is oncology, supported by a library of marine compounds…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- defenseworld.net1
- marketbeat.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.